These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 38346952)
1. Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins. Hinke DM; Anderson AM; Katta K; Laursen MF; Tesfaye DY; Werninghaus IC; Angeletti D; Grødeland G; Bogen B; Braathen R Nat Commun; 2024 Feb; 15(1):850. PubMed ID: 38346952 [TBL] [Abstract][Full Text] [Related]
2. Protection against H1N1 influenza challenge by a DNA vaccine expressing H3/H1 subtype hemagglutinin combined with MHC class II-restricted epitopes. Tan L; Lu H; Zhang D; Tian M; Hu B; Wang Z; Jin N Virol J; 2010 Dec; 7():363. PubMed ID: 21134292 [TBL] [Abstract][Full Text] [Related]
3. Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans. Nachbagauer R; Wohlbold TJ; Hirsh A; Hai R; Sjursen H; Palese P; Cox RJ; Krammer F J Virol; 2014 Nov; 88(22):13260-8. PubMed ID: 25210189 [TBL] [Abstract][Full Text] [Related]
4. Broadly neutralizing antibodies to combat influenza virus infection. Sun X; Ma H; Wang X; Bao Z; Tang S; Yi C; Sun B Antiviral Res; 2024 Jan; 221():105785. PubMed ID: 38145757 [TBL] [Abstract][Full Text] [Related]
5. Broadly Protective CD8 Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S J Virol; 2021 May; 95(12):. PubMed ID: 33827939 [TBL] [Abstract][Full Text] [Related]
6. Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes. Chiba S; Kong H; Neumann G; Kawaoka Y mBio; 2023 Aug; 14(4):e0062223. PubMed ID: 37466314 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Immune Response towards Generation of Universal Anti-HA-Stalk Antibodies after Immunization of Broiler Hens with Triple H5N1/NA-HA-M1 VLPs. Gromadzka B; Chraniuk M; Hovhannisyan L; Uranowska K; Szewczyk B; Narajczyk M; Panasiuk M Viruses; 2022 Mar; 14(4):. PubMed ID: 35458460 [TBL] [Abstract][Full Text] [Related]
15. Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge. Jang H; Meyers LM; Boyle C; De Groot AS; Moise L; Ross TM Hum Vaccin Immunother; 2020 Sep; 16(9):2042-2050. PubMed ID: 32783766 [TBL] [Abstract][Full Text] [Related]
16. Hemagglutinin stalk-based monoclonal antibody elicits broadly reactivity against group 1 influenza A virus. Huang J; Huang N; Fan M; Zhao L; Luo Y; Ding P; Tian M; Liu Q; Guo Y; Zhao J; Zheng Y; Zhang H; Ping J Virol J; 2020 Dec; 17(1):191. PubMed ID: 33287849 [TBL] [Abstract][Full Text] [Related]
17. Identification of Linear Peptide Immunogens with Verified Broad-spectrum Immunogenicity from the Conserved Regions within the Hemagglutinin Stem Domain of H1N1 Influenza Virus. Li S; Qiao Y; Xu Y; Li P; Nie J; Zhao Q; Chai W; Shi Y; Kong W; Shan Y Immunol Invest; 2022 Feb; 51(2):411-424. PubMed ID: 33078652 [TBL] [Abstract][Full Text] [Related]
18. Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses. Margine I; Krammer F; Hai R; Heaton NS; Tan GS; Andrews SA; Runstadler JA; Wilson PC; Albrecht RA; García-Sastre A; Palese P J Virol; 2013 Oct; 87(19):10435-46. PubMed ID: 23903831 [TBL] [Abstract][Full Text] [Related]
19. Computationally optimized broadly reactive vaccine based upon swine H1N1 influenza hemagglutinin sequences protects against both swine and human isolated viruses. Skarlupka AL; Owino SO; Suzuki-Williams LP; Crevar CJ; Carter DM; Ross TM Hum Vaccin Immunother; 2019; 15(9):2013-2029. PubMed ID: 31448974 [TBL] [Abstract][Full Text] [Related]
20. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype. Walz L; Kays SK; Zimmer G; von Messling V J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]